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ABSTRACT
Studies involving carbachol (1 00 M) treatment of cerebellar
granule cells for 1 , 3, 6, 9, 1 2 and 24 hr show a decrease in the
mRNA encoding for the muscannic m2 receptor. The response
was transient, decreasing m2 mRNA by 25 to 50% in 6 and 9 hr,
respectively. The data presented in this work were quantified by
nbonuclease protection assay, using a [P]-cRNA probe corre-
sponding to nucleotide +1 1 38 to 1 650 of the rat m2 muscannic
receptor. Because cerebellar granule cells express muscarinic
m2 and m3 receptors, we tested whether the carbachol-mediated
decrease in m2 mRNA resulted from a homologous or heterolo-
gous activation of muscannic receptors. At a 1 M concentration,
methoctramine specifically blocked the muscannic m2 receptor
and reversed carbachol’s action. These data suggested that
carbachol acts via a possible homologous activation of musca-
nnic m2 receptors. The half-life of the receptor mRNA measured
in the presence of actinomycin D with and without carbachol
were similar. Because carbachol treatments decrease the
steady-state levels of m2 mRNA without changing the half-life of
the message, we suggest that a carbachol treatment induces a
decrease in the transcription of the gene for the muscarinic m2
receptor.
Activation ofcholinergic muscarinic m2 receptors that inhibit
adenylyl cyclase induces a rapid receptor desensitization (T112
of 20 mm) in primary cultures of cerebellar granule cells (Con-
trera et al. , 1993). Because all muscarinic receptors belong to a
family of receptors that span the plasma membrane seven times
and couple to guanine nucleotide binding (G) proteins, the
mechanism of desensitization for muscarinic m2 receptors may
be similar to that of other receptors of the same family. A
model receptor could be the beta adrenergic receptor (Lohse et
at., 1990; Hadcock and Malbon, 1988; Collins et aL, 1989).
Briefly, the mechanism of desensitization for the beta2 adre-
nergic receptor, as it is understood today, proceeds in two steps.
The first and most rapid step involves the phosphorylation of
the receptor by BARK and protein kinase A (Benovic et al.,
1989; Lohse et al., 1990). This phosphorylation converts the
receptor to a low-affinity state. In addition, receptor sequestra-
tion also occurs rapidly. The second and slower step involves a
change in the mRNA content that encodes the beta2 adrenergic
receptor. The events that regulate gene transcription and trans-
lation of mRNA are still not completely understood for the beta
adrenergic receptor, although the increased formation of cyclic
AMP is important. It has been reported that the gene for the
beta2 adrenergic receptor might be regulated by a CRE, a cis-
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acting DNA sequence located upstream from the promoter
region. The addition of lipophilic cyclic AMP analogs to cell
cultures expressing beta2 adrenergic receptors induces a long-
term decrease in mRNA encoding the beta2 adrenergic receptor
and mimics the agonist-mediated response (Hadcock and Mal-
bon, 1988; Collins et at., 1989).
Short-term treatment of cerebellar granule cell cultures with
Carb initiates a mechanism of rapid desensitization of musca-
rinic m2 receptors similar to the mechanism described for beta2
adrenergic receptors. After long-term receptor stimulation by
agonist, changes in mRNA-encoding muscarinic receptors also
appear to be similar to the changes in mRNA-encoding beta2
adrenergic receptors. In addition, stimulation of beta2 adrener-
gic receptors increases the content of mRNA-encoding alpha1
adrenergic receptors, showing a cross-regulation between two
subtypes of the same receptor family (Morris et at., 1991). In
fact, in cerebellar granule cells, activation of muscarinic recep-
tors with Carb decreases the content of both muscarinic m2 and
m3 mRNAs, which are two of the five possible muscarinic
receptor subtypes (m1 to m5) expressed in brain (Fukamauchi
et al., 1991; McLeskey and Wojcik, 1990); moreover, no detect-
able amount of m5 mRNA is present in cerebellar granule cell
cultures (unpublished observations). There is the possibility
that these two muscarinic receptor subtypes may interact and
thereby mediate the agonist-induced decrease in m2 mRNA. In
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this report, we attempt to identify whether the regulation of
m2 mRNA results from homologous stimulation of muscarinic
m2 receptors and to further characterize the Carb-induced
decrease in muscarinic m2 mRNA content in cerebellar granule
cell cultures from rat.
Methods
Primary cell cultures of rat cerebellar granule cells. Primary
cell culture of rat cerebellar granule cells was prepared as previously
described (Thangnipon et at., 1983; McLeskey et at., 1990). Briefly,
these cultures were derived from cerebella dissected from 8-day-old rat
pups. The cerebella were incubated for 10 mm at 37’C with 0.025%
trypsin and triturated with a Pasteur pipet to dissociate the cells. These
cells were plated onto poly-L-lysine coated 10-cm Petri dishes (2.4 x
iO cells/dish). Cultures were grown in basal Eagle medium supple-
mented with 10% fetal calf serum, 25 mM potassium chloride, 100 U/
ml penicillin, 0.1 mg/ml streptomycin and 50 jg/ml gentamicin. Cul-
tures were placed in a humidified environment containing 6% C02/
95% air for 8 to 9 days before being used in various experiments. Within
24 hr of preparing the cultures, 10 j.M cytosine arabinoside was added
to the culture medium. All steps in the cell culture preparation were
performed in a class 100 hood/environment.
Extraction of RNA. RNA was extracted using the guanidium
thiocyanate/phenol-chloroform method with some modifications
(Chomczynski and Sacchi, 1987; Thompson and Sommercorn, 1992).
Briefly, the cells were scraped in a solution containing 4 M guanidium
thiocyanate, 25 mM sodium citrate, pH 7, 0.1 M 2-mercaptoethanol
and 0.5% sarcosyl. For every 1 ml of solution, 0.1 ml of 2 M sodium
acetate, 1 ml of phenol (saturated with water) and 0.4 ml of a mixture
of chloroform-isoamyl alcohol (49:1) were added to separate proteins
and DNA from RNA. After centrifugation (10,000 x g for 20 mm), the
aqueous phase (which contained the RNA) was collected and 2.5
volumes of ethanol were added, mixed and centrifuged for 20 mm at
10,000 x g. The precipitated nucleic acids were resuspended in 300 
of 4 M lithium chloride and centrifuged at 15,000 x g for 15 mm. The
pellet was resuspended in 300 Ml of 10 mM Tris, pH 7.4, 1 mM EDTA
and 0.5% sodium dodecyl sulfate and an equal volume of chloroform-
isoamyl alcohol (24:1) was added; the samples were mixed and centri-
fuged at 15,000 x g for 15 mm. The aqueous phase was collected and 2
M sodium acetate (pH 5.2) was added at a volume 1/10 of the original
sample volume. The RNA was pelleted, washed, dried and resuspended
in diethyl pyrocarbonate-treated H20. The content of total RNA was
determined by absorbance measurements at 260 nm.
Preparation of plasmid. cDNA fragment from the 3’ translated
and a portion of the untranslated region (position + 1138 to 1650) from
the m2-cDNA (Gocayne et al., 1987) was removed using SmaI-PstI and
subcloned into pBluescript SK+ (Stratagene). The in vitro transcrip-
tion was carried out on the SinaI linearized plasmid with 100 Ci of
[32P]CTP and 20 U of T7 polymerase at 3TC for 1 hr (Sambrook et
at., 1989). The length of the cRNA probe was 586 bases that comprises
70 bases of the plasmid polylinker region and 516 bases of the m2
mRNA.
For the structural protein cyclophilin, two different cDNA were used
and both provided similar results. One was a 645-base PstI fragment
from plasmid plBl5 (Milner and Sutcliffe, 1983; Danielson et al., 1988)
that was subcloned into the pGEM 4Z plasmid (Promega) to generate
plasmid pl5GI (Riva and Mocchetti, 1991). The in vitro transcription
of this plasmid, linearized with NcoI, with T7 polymerase and 1 jCi of
[32P]CTP generates a 304-base [32P]cRNA probe which comprises 294
bases of the cyclophilin mRNA and 10 bases of plasmid polylinkers.
The other cyclophilin cDNA comprised positions 411 to 705 and was
subcloned into the EcoRI-HindIII site of pGEM1 plasmid (Promega).
This plasmid was linearized with EcoRI, and [32P]cRNA probe was
synthesized using SP6 polymerase and 1 MCi of [32PJCTP. The probe
(301 bases) comprised 294 bases of the cyclophilin mRNA and 7 bases
of plasmid polylinkers. Cyclophilin cRNA was used as an internal
standard to control for artifacts due to extraction of RNA from cere-
bellar granule cell cultures.
RNase protection assay. The m2 and cyclophilin probes (2.5 x 10
cpm) and 40 g of total RNA from cerebellar granule cells were
hybridized overnight at 50’C in 20 l of hybridization buffer composed
of 80% formamide, 0.4 M NaCl, 1 mM EDTA and 40 mM 1,4-
piperazine(ethanesulfonic acid), pH 6.4. RNase buffer (200 l) contain-
ing 10 zg/ml RNase A and 200 U/ml RNase Ti was added to each tube
and then incubated for 30 mm at 25’C. The RNase mixture was
inactivated by the addition of 20 l of a mixture containing 10 mg/ml
proteinase K and 20% sodium dodecyl sulfate. The RNase-protected
hybrids were then precipitated with ethanol and separated on a 5%
polyacrylamide, 8 M urea gel. Gels were dried under vacuum at 80’C
and exposed to X-ray autoradiographic film with intensifying screens.
RNA calculation of m2 mRNA was quantified by either scanning the
protected fragment with a LKB laser densitometer or obtaining the
optical density of a digitized image of the band with the SAMBA 4000
(Dynatech Laboratories, Chantilly, VA). The peak densitometry area
of the autoradiogram of the m2 mRNA was normalized by the peak
densitometry area of the autoradiogram of the cyclophilin mRNA.
Thus, the relative amount of m2 mRNA was expressed as the ratio of
arbitrary units of m2 mRNA to arbitrary units of cyclophilin mRNA
obtained within each experiment. Multiple experiments were averaged
by first converting the ratio of m2/cyclophilin mRNA in the control
group to 100% for each experiment and normalizing the treatment
groups to their respective control value. Hence, despite the possible
varying recovery of RNA throughout all of the described steps, differ-
ences in m2 mRNA values represent differences due to the pharmaco-
logical manipulation.
Calculations of m2 mRNA half-life, rate constant and rate of
decline. Act D was added to the cell cultures to block transcription.
Thus, the rate of loss in m2 mRNA content over time reflects the half-
life of the mRNA. Data from each study were normalized to the control
value and the control value was kept at 100% (the amount of m2 mRNA
present in the cell culture before the addition of actinomycin D). The
results from these studies were analyzed by the Manual of Pharmaco-
logic Calculations Computer program (Tallarida and Murray, 1992),
which provides the fractional rate constant, k (hr’). The half-life,
T112 value (sec), was calculated by the following equation: T112 (hr) =
0.693/k (hr’). The rate of decline was calculated from the following
equation: rate of decline (% . hr’) = [m2mRNA](% of control) . k
(hr).
Statistical analyses. Statistical differences between groups of par-
ametric data were analyzed by either the Student’s t test or the analysis
of variance test (Tallarida and Murray, 1992). Nonparametric data
were analyzed by the Kruskal Wallis test followed by the Mann
Whitney U test, which determined differences between groups of a
multiple group study (Roscoe, 1975). The individual m2/cyclophilin
mRNA ratios, which were normalized to percentages, were used in
these analyses. Statistical significance was selected at the probability
level of P < .05.
Results
Cerebellar granule cells express m2 mRNA, as demonstrated
by Northern blot analysis, and their content decreases after an
exposure to a muscarinic receptor agonist (Fukamuchi et at.,
1991). We have used an RNase protection assay which pos-
sesses a greater sensitivity than Northern blot to further char-
acterize the m2 mRNA down-regulation. Initially, we attempted
to verify the report by Fukamuchi et at. (i99i) on the down-
regulation of m2 mRNA by Carb. The relative amount of m2
mRNA was determined in primary cultures of cerebellar gran-
ule cells after treatment with 100 M Carb. After 1-, 3-, 6-, 9-,
12- and 24-hr treatments with Carb, a statistically significant
decrease in the mRNA content encoding the muscarinic m2
receptor was observed at the 3rd, 6th and 9th hr (fig. 1). The
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Fig. 1. Garb treatment (1 00 M) decreases m2 mRNA content in care-
bellar granule cells. In order to average the different experiments, the
control group in each experiment was normalized to 100%. Values are
mean ± SE. for an average of five experiments. The dashed line
represents the control ± SE. Statistical analysis showed the Carb
treatment to be different than the control group (P < .01 by the analysis
of variance. Subsequent comparisons between groups were performed
by the Student’s t test and this is represented as   < .05.
maximal reduction in m2 mRNA content appeared after the
9th hr of Carb treatment. The m2 mRNA content returned to
control values after 12 and 24 hr of continuous Carb treatment.
The results are shown as the average of five experiments in
which the relative amount of m2 mRNA present in the control
for each experiment was made 100% and the subsequent
amounts measured after different Carb treatment times were
calculated relative to the appropriate control. In the five exper-
iments, the peak response to Carb varied from 3 to 9 hr. These
experiments were originally performed without using the cyclo-
philin probe as an internal standard. Subsequent experiments
included the cyclophilin riboprobe for a more precise determi-
nation of the relative amount of m2 mRNA.
Ribonuclease protection assay, using total RNA extracted
from cerebellar granule cells and [32P]cRNA probes for mus-
carinic m2 receptors and cyclophilin, shows two protected frag-
ments of 516 bases (reflecting the m2 mRNA) and 294 bases
(reflecting the cyclophilin mRNA). Specificity of the m2-cRNA
probe was confirmed by showing the presence of in2 mRNA in
rat heart (fig. 2A). No protected fragment was observed in
samples containing tRNA (data not shown). With increasing
amounts of total RNA, the amount of each protected fragment
reflecting m2 and cyclophilin mRNA also increased (fig. 2 A
and B). The ratio of m2 mRNA to cyclophilin mRNA is similar
for each amount of total RNA present during the RNase
protection assay, indicating that the cyclophilin riboprobe
would be an adequate internal standard for the relative quan-
tification of m2 mRNA in this assay (fig. 2B). To assume that
the RNase protection assay was a quantitative method for
measuring changes in the amount of muscarinic m2 mRNA
present within cerebellar granule cells, we used an amount of
total RNA which was on the linear portion of the RNA curve,
and ratios of m2 mRNA to cyclophilin mRNA were calculated
to account for the variability in RNA extraction.
Figure 3 shows that cycloheximide (30 .zM, 6 hr) increases
the m2 mRNA content and that Carb (100 tM, 6 hr), even in
the presence of cycloheximide, decreases the m2 mRNA content
by 47%. These results are similar to those shown in figure i.
In these studies with cycloheximide, the cyclophilin mRNA
content did not change and all results are shown as ratios of
m2 mRNA content per cyclophilin mRNA content.
Primary cultures of cerebellar granule cells express both
muscarinic m2 and m3 receptors and Carb shows no specificity
for these subtypes. The decrease in m2 mRNA content could
result from Carb’s specific stimulation of only muscarinic m2
receptors, or muscarinic m3 receptors, or from an activation by
Carb of both receptor subtypes. To address this point, meth-
octramine (1 MM), which at this concentration blocks more
than 80% of the muscarinic m2 receptors and has no action at
muscarinic m3 receptors, was used (McLeskey et al., i990;
McLeskey and Wojcik, 1990). As shown in figure 4, methoctra-
mine alone (1 M, 6 hr) did not alter the m2 mRNA content
present in these cell cultures, but it prevented the Carb (100
zM, 6 hr)-mediated decrease in m2 mRNA. In order to detect
the m2 mRNA more readily, cycloheximide (30 M, concur-
rently administered with Carb and/or methoctramine) was also
included during the drug treatment.
Any change in steady-state levels of m2 mRNA might reflect
either a decrease in transcription of the gene for muscarinic m2
receptors or a destabilization of the m2 mRNA. The inhibitor
of transcription, Act D (10 /g/ml), was added to the culture
medium to block the transcription of the gene for muscarinic
m2 receptors, and the rate of decline and half-life of the m2
mRNA were determined. Both rate of decline and half-life are
thought to reflect the stability of the m2 mRNA. The Act D
treatment alone decreases m2 mRNA with a T112 of approxi-
mately 1 to 1.5 hr (table 1 and figure 5). This T112 is similar to
that reported by Collins et at. (1989) for the beta2 adrenergic
receptor expressed in DDT1-MF-2 cells. If Act D was added
simultaneously with Carb (100 M) and the relative amounts
of m2 mRNA were determined after 1, 1.5 and 2 hr, the T112
values of the m2 mRNA were similar for cell cultures receiving
Act D and cultures receiving Carb plus Act D (data not shown).
When Act D was added to cell cultures already treated with
Carb for 6 hr, the average T112 of the m2 mRNA was approxi-
mately 1.3 hr (table 1; fig. 5 shows one representative experi-
ment of four). T112 values for the control group (Act D given
after a 6-hr vehicle treatment) and Carb-treated group (Act D
given after a 6-hr Carb treatment) were not statistically differ-
ent. Cerebellar granule cells treated with Carb for 6 hr also
showed, after averaging four experiments, a statistically signif-
icant decrease by 45% in the amount of m2 mRNA present in
the cells before beginning the Act D treatment (table 1; a Carb-
induced decrease in m2 mRNA is also found in fig. 5). Because
of the decreased amount of message, the average rate of decline
calculated for the Carb plus Act D treatment was 23 ± 9% . hr’
and for the control, Act D treatment was 56 ± 13% . hr’ (table
1). The rates of decline in m2 mRNA for the Carb plus actini-
mycine D treatment was 59% lower than the actinomycune D
group (P < .1, Student’s t test). Because the steady-state
measurement of the m2 mRNA decreases with a 6- to 9-hr
treatment with Carb, we believe that a reduced transcriptional
rate of the gene encoding for the muscarinic m2 receptor might
have occurred.
Discussion
In many instances, stimulation of neurotransmitter receptors
by agonists either changes the mRNA encoding for that recep-
tor (homologous regulation) or regulates mRNA content encod-
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ing for another neurotransmitter receptor (heterologous regu-
lation). An example of both types of regulation exists in the
DDT1-MF-2 vas deferens clonal cells. In these cultures, long-
term exposure to beta adrenergic receptor agonists both de-
creases mRNA content encoding for beta2 adrenergic receptors
(a form of homologous regulation) and increases mRNA encod-
ing for alpha1 adrenergic receptors (a form of heterologous
regulation) (Hadcock and Malbon, 1988; Collins et al., 1989;
Morris et at., 1991). In a somewhat similar manner, the steady-
state amount of mRNA encoding for neuronal muscarinic m2
and m3 receptors decreased after a long-term treatment with
Carb in primary cultures of cerebellar granule cells (Fukamuchi
et at., 1991). In that report, atropine and pirenzepine reversed
Carb’s action. However, neither Carb nor the two antagonists
studied were able to descriminate between the two muscarinic
receptor subtypes (McLeskey et at., 1990; McLeskey and
Wojcik, 1990). Because we were interested in understanding
Fig. 2. Hybridization of [‘P]m-cRNA ri-
boprobe to mRNA encoding for musca-
rinic m2 receptors increases proportion-
ately with increasing amounts of total
RNA from primary cultures of cerebellar
granule cells. A) A representative autora-
diogram showing an increase in the pro-
tected fragment that reflects either them2
mRNA or cyclophilin mRNA with increas-
ing amounts of total RNA. Quantitation of
the autoradiogram is shown in panel B.
B) Graph shows the amount (intensity
units = optical density x square surface
area) of m2 mRNA (#{149})and cyclophilin
mRNA 4 quantified by an image ana-
lyzer. The ratio of m2 mRNA/cyclophilin
mRNA (0) is also shown. This is one
experiment representative of three.
the type of regulation (homologous or heterologous) of mRNA
encoding muscarinic m2 receptors, we asked whether the acti-
vation of only the muscarinic m2 receptor would result in a
decreased content of m2 mRNA. We have previously reported
methoctramine (1 M) to specifically antagonize muscarinic m2
receptors without blocking muscarinic m3 receptors. If the
Carb-mediated decrease in m2 mRNA resulted from an activa-
tion of only muscarinic m2 receptors (homologous regulation),
1 ,.M methoctramine ought to block Carb’s response. Alterna-
tively, methoctramine might not interfere with Carb’s action if
the stimulation of muscarinic m3 receptors were required (het-
erologous regulation). As shown in this report, methoctramine
prevented the decrease in m2 mRNA content induced by Carb.
These data suggest that a specific activation of muscarinic m2
receptor mediates the decrease in m2 mRNA; thus, the regula-
tion appears to be homologous.
Cycloheximide accumulates m2 mRNA most likely by inhib-
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In this report, we also characterized the Carb-induced de-
crease in m2 mRNA. A decrease in steady-state levels of m2
mRNA may result from a decrease in transcription of the gene
encoding for the muscarinic m2 receptor or a decrease in sta-
bility of the m2 mRNA. In order to address this issue, we treated
cell cultures with Act D, an inhibitor of transcription. Interest-
ingly, the half-life of the m2 mRNA in the Act D-treated cells
was short, from 1 to 1.5 hr, indicating a rapid expression and
metabolism of this message. This observation may not be too
surprising because the mRNA encoding for the beta2 adrenergic
receptors in DDT1-MF-2 cells also has a short half-life of
approximately 1.3 hr (Collins et at., 1989).
In cerebellar granule cells treated with Carb for 6 hr, the
half-life of the m2 mRNA was 1.3 hr, which was similar to the
control group containing Act D that was added to the cell
cultures after a 6-hr vehicle treatment. Moreover, cerebellar
granule cells treated with Carb for 6 hr showed a 45% decrease
in the amount of m2 mRNA present in the cells before beginning
the Act D treatment. Because of this initial decreased amount
of message, the rate of decline calculated for the Carb plus Act
D treatment was statistically different from the rate of decline
of m2 mRNA for the control (Act D alone). These results
suggest that the Carb treatment causes a decreased transcrip-
tion of the gene for muscarinic m2 receptors without affecting
the stability of the m2 mRNA. These observations agree with a
recent report by Habecker and Nathanson (1992) which showed
iting the degradation of RNA. Carb, when added concomitantly
with cycloheximide, still decreased m2 mRNA. This finding
suggests that Carb’s action does not require de novo protein
synthesis such as the stimulation of an inhibitory transcrip-
tional factor to reduce the content of m2 mRNA. This raises
the possibility that activation of muscarinic m2 receptors down-
regulates muscarinic m2 receptor gene expression. The mecha-
nism mediating the decreased gene expression is unknown. It
might be possible that a cyclic AMP-dependent process is
involved, because muscarinic m2 receptors are coupled to the
inhibitory adenylate cyclase.
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the m2 mRNA content to decrease in embryonic chicken heart
Fig. 3. Carb (1 00 M) decreases the muscarinic m2 mRNA content even
in the presence of cycloheximide (30  Cerebellar granule cell cultures
were exposed to both Carb and cycloheximide for 6 hr and m2 and
cyclophilin mRNA were determined. The cyclophilin mRNA content was
notaffected by the cycloheximide treatment. Data represent the ratio of
m2 mRNA and cyclophilin mRNA autoradiographic bands and are the
average of three experiments. In order to average the experiments, each
experimental control was normalized to 100%. Values are shown as
means ± S.E.   < .05 when compared to control with no cycloheximide
treatment; and   < .05 when compared to the control with cyclohexi-
mide treatment using the Kruskal Wallis nonparametric test with multiple
comparisons being performed by the Mann Whitney U test.
g
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Fig. 4. Methoctramine (1 M, 6 hr) blocks the Carb-induced decrease in
m2 mRNA content in cerebellar granule cells. Cycloheximide (30 zM, 6
hr) was included in this study because it increases the muscarinic m2
mRNA content in cerebellar granule cells and, in its presence, Carb is
still seen to decrease m2 mRNA content. Neither cycloheximide nor Carb
affected the cyclophilin mRNA content. The figure shows the ratio of
muscarinic m2 mRNA content to cyclophilin mRNA content and the
results are the average of three experiments. In order to average the
experiments, each experimental control was normalized to 100%. Values
are shown as means ± SE.   < .05 when compared to control using
the Kruskal Wallis nonparametric test with multiple comparisons being
performed by the Mann Whitney U test.
TABLE 1
Calculations of fractional rate constant, T#{189}and rate of decline for
m2 mRNA in the presence and absence of 100 MM Carb
Results represent the average ± SE. of four experiments. Statistical analysis of
the T#{189}values, fractional rate constants (k) and rate of decline values for the two
groups showed no significant differences by the Students t test, whereas statistical
differences were found for the initial amounts of m2 mRNA (%) by the t test.
Tune=6hr mmRNA T k Rate of
% hr hr’ %.hr’
ActD 100±14 2±0.6 0.55±0.13 56±13
Carb + Act D 55 ± 8* 1 .5 ± 0.4 0.41 ± 0.1 1 23 ± 9
* P < .05 when co mpared to the Act D treatment.
6 7 8 9
14-s after Cat-b or Vehicle
Fig. 5. Relative amounts of m2 mRNA after Act D treatment in control
cerebellar granule cell cultures (0) and 6-hr Carb-treated cell cultures
(#{149}).Total RNA was isolated at the indicated times and the amount of m2
and cyclophilin mRNA was determined. The figure shows the logarithmic
amounts of m2/cyclophilin mRNA after 1 , 2 and 3 hr with Act D and is
one of four representative experiments. After 6 hr with Carb, the ratio of
m2 mRNA per cyclophilin mRNA was reduced by 47% (#{149}at t = 6 hr).
Calculations of the combined values from the four experiments are shown
in table 1.
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cells after chronic Carb treatment. There also was no change
in the half-life of the m2 mRNA. Interestingly, the Carb-
induced decrease in m2 mRNA in chicken heart cells was
maintained with continuous Carb treatment, whereas only a
transient decrease in m2 mRNA was found in cerebellar granule
cells. It is possible that the signal(s) mediating the transient
decrease in m2 mRNA was short-lived.
Many similarities exist between the effects of long-term
agonist treatment of either beta2 adrenergic or muscarinic m2
receptors. However, the beta2 adrenergic receptor couples to the
stimulatory adenylyl cyclase, whereas the muscarinic m2 recep-
tor couples to the inhibitory adenylyl cyclase. It is, however,
unclear whether the mechanism underlying the transient de-
crease in m2 mRNA in cerebellar granule cell cultures is similar
to the mechanism mediating the change in beta2 mRNA result-
ing from beta adrenergic receptor stimulation.
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